ecf2016

=Annual ECF Consortium meeting= =Hertford, UK= =16 - 18 May 2016=

@http://ilvac.net/

@http://www.deverevenues.co.uk/en/venues/ponsbourne-park
 * Venue**

Closest rail station: @http://www.nationalrail.co.uk/stations/cuf/details.html

**Objectives**
 * 1) Review the past 12 months, products, results delivered
 * 2) Plan the next 24 months, products, deliverables
 * 3) Get inputs from the External Advisory Committee and Funding agencies
 * 4) Propose improvements to consortium operation

Agenda

 * Day 1 Monday 1 February**
 * 0900 || Session 1. Opening, welcome, objectives || Vish Nene ||
 * || Agenda, process, introductions || Peter Ballantyne ||
 * 1000 || Session 2. Consortium ‘annual report’ || Vish Nene ||
 * 1030 || Break ||  ||
 * 1100 || Session 3. Revisiting the 2015 meeting – plans, results; what we said we would do! || Interactive exercise ||
 * 1200 || Session 4. Year 2 in review – the research teams
 * Objective 1: To improve aspects of the current live infection and treatment method ECF vaccine
 * Objective 2: To induce antibody based immunity by targeting the sporozoite stage of the parasite.
 * Objective 3: To induce T-cell mediated immunity by targeting the schizont stage of the parasite
 * Objective 4: Application of evolutionary and comparative pathogen genomics to ECF vaccinology

Convenors: - Results - Insights - Conclusions - Significance - Plans ||
 * Obj 1: Jeremy
 * Ob 2: Vish
 * Ob 3: Ivan
 * Ob 4: Joana || 4 parallel conversations to co-generate 2015 research highlights per objective on PPT to present on day 2
 * 1300 || Lunch ||  ||
 * 1400 || Session 4. Year 2 in review – the research teams

Convenors: - Results - Insights - Conclusions - Significance - Plans ||
 * Obj 1: Jeremy
 * Ob 2: Vish
 * Ob 3: Ivan
 * Ob 4: Joana || 4 parallel conversations to co-generate 2015 research highlights per objective on PPT to present on day 2
 * 1600 || Break ||  ||
 * 1630 || Session 5. Year 2 in review – The focus groups
 * Group 1: Infectivity assay of sporozoites - Ine
 * Group 2: Immune responses to p67 - Vish
 * Group 3: Sporozoite antigen discovery – Lucilla
 * Group 4: Reagents – communal resources – Lotte

- Results - Activities - Conclusions - Plans ||
 * Group 5: Schizont antigen discovery - Tim
 * Group 6: T. parva genome resources - Joana
 * Group 7: Antigen delivery systems - Don
 * Group 8: Proof-of concept - Ivan || Two sets of parallel conversations on each focus group area on PPT to present on day 2:
 * 1745 || Report from the recent Oxford meeting || Vish ||
 * 1815 || Session 6. EAC member feedback – seen and heard so far || Feedback ||
 * 1830 || END of day 1 ||  ||
 * || Zebu Club option ||  ||


 * Day 2 Tuesday, 2 February**
 * 0830 || Recap and plans for the day ||  ||
 * 0845 || Session 7. ECF research highlights
 * Proteomics of MHC class I-associated peptides by Nicola
 * BHV4 as an antigen delivery system by Gaetano
 * Construction of p67C nanoparticles by Vish ||  ||
 * 0915 || Session 8. Year 2 in review / year 3 in prospect – Short (10 min) presentations by research teams by objectives

- Results - Insights - Conclusions - Significance - Plans Q&A || - Results - Activities - Plans Q&A || Session 12b. Inter-lab conversations || Members
 * Obj 1: Jeremy
 * Ob 2: Vish
 * Ob 3: Ivan
 * Ob 4: Joana || For each:
 * 1045 || Break ||  ||
 * 1115 || Session 9. Year 2 in review / year 3 in prospect – Short (5 min) presentations by the focus groups || For each:
 * 1215 || Session 10. Years 3 and 4 results framework validation and confirmation of expected activities and roles – by objectives || Group work ||
 * 1300 || Lunch ||  ||
 * 1400 || Session 11. Delivering program goals – years 3 and 4 critical program-level milestones and success factors || Interactive exercise ||
 * 1445 || Idea for 2016: W orkshop on next gen seq in the context of a vet vaccine network meeting that took place in Roslin || Tim/Ivan ||
 * 1500 || Break ||  ||
 * 1530 || Session 12a. Program management meeting (PMC and EAC members)

Others ||
 * 1730 || Brief reports from session 12 ||  ||
 * 1800 || Session 13. EAC member feedback – seen and heard so far || Feedback ||
 * 1830 || END of Day 2 ||  ||
 * 1830 || Barbecue on campus ||  ||

Plenary on communicating the consortium’s work ||  ||
 * DAY 3 Wednesday, 3 February**
 * 0830 || Recap and plans for the day ||  ||
 * 0845 || Session 14. Documenting program results and outputs ||  ||
 * 0900 || Work on products, blogposts, photo-reports, interviews ||  ||
 * 1300 || Lunch ||  ||
 * 1400 || Work on products ||  ||
 * 1600 || Session 15. Products show and tell
 * 1700 || Session 16. Closing – comments from EAC, investors, management, participants ||  ||
 * 1730 || END of day 3 ||  ||

Participants

 * ECF CONSORTIUM MEETING ||
 * Name || Institution || Email address ||
 * Vish Nene || ILRI || v.nene@cgiar.org ||
 * Lucilla Steinaa || ILRI || l.steinaa@cgiar.org ||
 * Nicholas Svitek || ILRI || n.svitek@cgiar.org ||
 * David Kiereini || ILRI || d.kiereini@cgiar.org ||
 * James Nyagwange || ILRI || j.nyagwange@cgiar.org ||
 * Sam Oyolla || ILRI || s.oyola@cgiar.org ||
 * Peter Ballantyne || ILRI || p.ballantyne@cgiar.org ||
 * Don Knowles || Washington State University/USDA-ARS || dknowles@vetmed.wsu.edu ||
 * Joana Da Silva || Institute of Genome Sciences-Uni of Maryland || jcsilva@som.umaryland.edu ||
 * Kyle Tretina || Institute of Genome Sciences-Uni of Maryland || kyletretina@gmail.com ||
 * Dirk Werling || Royal Veterinary College, London || Dwerling@RVC.AC.UK ||
 * Ivan Morrison || University of Edinburgh || ivan.morrison@roslin.ed.ac.uk ||
 * Tim Connelley || University of Edinburgh || timothy.connelley@roslin.ed.ac.uk ||
 * Fred Fellouse || University of Toronto || fellouse@gmail.com ||
 * Nicola Ternette || University of Oxford || nicola.ternette@ndm.ox.ac.uk ||
 * Jeremy Salt || Galvmed || Jeremy.Salt@galvmed.org ||
 * George Chaka || CTTBD - Malawi || mihji_chaka2@yahoo.co.uk ||
 * Ine De Goyse || ITM Antwerp || idegoeyse@itg.be ||
 * Dirk Geysen || ITM Antwerp || dgeysen@itg.be ||
 * Morten Nielsen || Fundacion Instituto Investigaciones Biotecnologicas (FIIB) Argentina/Technical Univesity of Denmark || mniel@cbs.dtu.dk ||
 * Niall MacHugh || University of Edinburgh || niall.machugh@roslin.ed.ac.uk ||
 * ECF EAC ||  ||   ||
 * Simon Draper || University of Oxford || simon.draper@ndm.ox.ac.uk ||
 * Shahid Khan || Leiden University, Netherlands || S.M.Khan@lumc.nl ||
 * Tomas Hanke || University of Oxford || tomas.hanke@ndm.ox.ac.uk ||
 * BMGF & USAID/USDA-ARS ||  ||   ||
 * Nick Juleff || Bill and Melinda Gates Foundation || Nick.Juleff@gatesfoundation.org ||
 * Gaetano Donofrio || University Of Parma || gaetano.donofrio@unipr.it ||
 * Lindsay Fry || Washington State University || lfry@vetmed.wsu.edu ||
 * Lindsay Parish || USAID || lparish@usaid.gov ||
 * William Davis || Washington State University || davisw@vetmed.wsu.edu ||